Fabian Higel

Shedding of glycan‐modifying enzymes by signal peptide peptidase‐like 3 ( <scp>SPPL</scp> 3) regulates cellular N‐glycosylation

Ulrike Künzel, Fabian Higel, Peer‐Hendrik Kuhn et al. · The EMBO Journal · 2014 · 109 citations · Full text

Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals

Fabian Higel, Uwe Demelbauer, Andreas Seidl et al. · Analytical and Bioanalytical Chemistry · 2013 · 58 citations · Full text

Fluorescent Label, Glycobiology, Biological Mass Spectrometry +17

N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance

Fabian Higel, Theresa Sandl, Chi-Ya Kao et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 53 citations · Full text

Immunocytochemical Technique, Glycobiology, Immunology +19

Towards maximum acceleration of monoclonal antibody development: Leveraging transposase-mediated cell line generation to enable GMP manufacturing within 3 months using a stable pool

Valerie Schmieder, Juergen Fieder, Raphael Drerup et al. · Journal of Biotechnology · 2022 · 40 citations · Full text

Engineering, Immunology, Cell Culture +23

<i>Yersinia enterocolitica</i> Infection and <i>tcaA</i> -Dependent Killing of <i>Caenorhabditis elegans</i>

Britta Spanier, Mandy Starke, Fabian Higel et al. · Applied and Environmental Microbiology · 2010 · 32 citations · Full text

Pathogenic Microbiology, Microbial Pathogens, Pathogen Detection +21